Notably, the upregulation of these anti-cancer pathways is independent of the cancer mutation status, as this phenotype was observed in both WT CM/CDDO-Me- and KEAP1 KO CM/CDDO-Me-treated macrophages. This evidence concerns the gene KEAP1 and cancer.